| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/22/2013 | CN1643143B Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 05/22/2013 | CN1384759B Single-stranded oligodeoxynucleotide mutation vectors |
| 05/22/2013 | CN103119161A Heterologous expression of fungal polyketide synthetic gene in yeast |
| 05/22/2013 | CN103119155A Media, kits, systems and methods for the micropropagation of bamboo |
| 05/22/2013 | CN103114100A Beta-glucosaccharase gene S-bgl3 and application thereof |
| 05/22/2013 | CN103114094A Amphioxus endonuclear protein, and expression gene and application thereof |
| 05/22/2013 | CN103114087A RNA(Ribonucleic Acid)and application thereof in diseases of cardiovascular system |
| 05/22/2013 | CN103114079A Preparation of serologic H-Y antigen gene DBY antibody and XY sperm immune sorting method thereof |
| 05/22/2013 | CN103114078A Plant antivirus related protein as well as encoding genes and application thereof |
| 05/22/2013 | CN103114076A Rice leaf color control gene heme oxygenase2 (HO2) and application thereof |
| 05/22/2013 | CN103114075A Cattle trophoderm stem cell system establishment method |
| 05/22/2013 | CN103114074A Method for building cGVHD (chronic graft-versus-host disease) model of mouse allogene after bone marrow transplantation |
| 05/22/2013 | CN103114073A Method for removing cells from human amnion |
| 05/22/2013 | CN103114072A Method for largely extracting active epithelial cells |
| 05/22/2013 | CN103114071A Method for rapidly and concentratedly preparing porphyra haitanensis protoplast |
| 05/22/2013 | CN103114070A Application method of single-cell separator |
| 05/22/2013 | CN103113627A Polysaccharide/Matrigel compound gel membrane for cell culture as well as preparation method and application thereof |
| 05/22/2013 | CN103113471A Bispecific monoclonal antibody resisting clenbuterol hydrochloride and olaquindox and preparation method of bispecific monoclonal antibody |
| 05/22/2013 | CN103113470A Genetically engineered lymphocyte targeting Human EGFR (Epidermal Growth Factor Receptor), preparation method and application of genetically engineered lymphocyte |
| 05/22/2013 | CN103113464A Natural human erythropoietin analogue |
| 05/22/2013 | CN103113463A Nuclear reprogramming factor |
| 05/22/2013 | CN102492648B Preparation method of porous chitosan scaffold |
| 05/22/2013 | CN102382187B FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene |
| 05/22/2013 | CN102352342B Method for amplifying cytokine induced kill cells (CIK) and CIK cell preparation |
| 05/22/2013 | CN102286088B DREB (Dehydration Responsive Element Binding) transcription factor of plant as well as encoding gene and application thereof |
| 05/22/2013 | CN102172237B Cell cryopreserving liquid as well as preparation method and application thereof |
| 05/22/2013 | CN102168061B Human lung cell BEAS-2B/CYP2A13, and preparation method and application thereof |
| 05/22/2013 | CN101919381B Preserving fluid of hepatic cells for biological artificial liver and preparation method thereof |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101838631B Method for preparing suspension culture cell line of gynura bicolor embryonic cells and special culture medium thereof |
| 05/22/2013 | CN101778934B CD34 stem cell-related methods and compositions |
| 05/22/2013 | CN101688185B Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection |
| 05/22/2013 | CN101636497B Improved halohydrin epoxidase |
| 05/22/2013 | CN101506349B A method to manufacture effective bioreactor |
| 05/22/2013 | CN101469019B Cellular membrane protein DERLIN-1, preparation and use thereof |
| 05/21/2013 | US8445764 Maize variety hybrid 10872490 |
| 05/21/2013 | US8445748 Flavonoid 3′,5′ hydroxylase gene sequences and uses therefor |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445520 Tricyclic compounds, compositions, and methods |
| 05/21/2013 | US8445453 CCR ligands for stem cell homing |
| 05/21/2013 | US8445282 Means to culture cochineal insects in an artificial medium |
| 05/21/2013 | US8445281 In vitro exposure of immature oocytes to BDNF enhances generation of embryonic stem cells |
| 05/21/2013 | US8445280 Method for creating perfusable microvessel systems |
| 05/21/2013 | US8445279 Cultured cell construction containing spheroids of mesenchymal stem cells and utilization thereof |
| 05/21/2013 | US8445278 Process for producing decellularized biological tissues |
| 05/21/2013 | US8445277 Rejuvenation or preservation of germ cells |
| 05/21/2013 | US8445276 Device and method for growing and analyzing cells |
| 05/21/2013 | US8445275 Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) |
| 05/21/2013 | US8445273 Stem cell aggregate suspension compositions and methods of differentiation thereof |
| 05/21/2013 | US8445272 Method of stimulating NKT with 6″-amino-6″-deoxygalactosylceramides |
| 05/21/2013 | US8445270 Immortalized avian cell lines and use thereof |
| 05/21/2013 | US8445269 Method for generating pluripotent stem cells |
| 05/21/2013 | US8445261 Apparatus for holding cells |
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8445231 Cytochrome P450s and uses thereof |
| 05/21/2013 | US8445193 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8444969 Neutrophil-depleted platelet rich plasma formulations for cardiac treatments |
| 05/21/2013 | US8444965 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | CA2588351C Block copolymers of polycaprolactone and poly (propylene fumarate) |
| 05/21/2013 | CA2587885C Human serum for cell culture |
| 05/21/2013 | CA2561830C Monoclonal antibodies with specificity for fetal erythroid cells |
| 05/21/2013 | CA2560209C Tissue repair |
| 05/21/2013 | CA2558946C Novel method for the preparation of embryoid bodies (ebs) and uses thereof |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2370405C Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch |
| 05/21/2013 | CA2360916C Apparatus and methods for producing and using high-density cells and products therefrom |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/16/2013 | WO2013071154A1 Cyclin a1-targeted t-cell immunotherapy for cancer |
| 05/16/2013 | WO2013071151A1 Kit comprising serum replacement and labile factors |
| 05/16/2013 | WO2013071123A1 Injectable silk fibroin foams and uses thereof |
| 05/16/2013 | WO2013071096A1 Composite tissue graft and materials and methods for its production and use |
| 05/16/2013 | WO2013071063A1 Brown adipocyte progenitors in human skeletal muscle |
| 05/16/2013 | WO2013071050A1 Brown adipocyte progenitors in human skeletal muscle |
| 05/16/2013 | WO2013070880A1 Fibroblasts for treatment of degenerative disc disease |
| 05/16/2013 | WO2013070843A1 Genetically modified cells and methods for making activated sugar-nucleotides |
| 05/16/2013 | WO2013070807A1 Niche targeting of quiescent cancer stem cells |
| 05/16/2013 | WO2013070778A1 Silica-matrix forming compositions, materials formed therefrom, and methods of using the same |
| 05/16/2013 | WO2013070765A1 Assay for the prediction of therapeutic effectiveness or potency of mesenchymal stem cells, and methods of using same |
| 05/16/2013 | WO2013070563A1 Treatment of autoimmune and inflammatory disorders by inhibition of blimp-1 |
| 05/16/2013 | WO2013070433A1 Targeting an amphiregulin-derived cell surface neo-epitope |
| 05/16/2013 | WO2013069962A1 Preparation method for multipotent cells |
| 05/16/2013 | WO2013069661A1 Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor |
| 05/16/2013 | WO2013069503A1 Stem cell isolation method |
| 05/16/2013 | WO2013069452A1 Method for observing stem cells, method for removal of cell region in state tending toward differentiation, and device for observing stem cells |
| 05/16/2013 | WO2013069016A2 Long lasting drug formulations |
| 05/16/2013 | WO2013069010A1 Methods for individually optimizing a cancer treatment |
| 05/16/2013 | WO2013068476A1 Neurotoxins exhibiting shortened biological activity |
| 05/16/2013 | WO2013068413A1 Rod cell-specific promoter |
| 05/16/2013 | WO2013067964A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 05/16/2013 | WO2013067928A1 Construct for regulating fertility of plant pollens and usage thereof |
| 05/16/2013 | WO2013067873A1 Anti-influenza virus nucleic acid, peptide nucleic acid and formulation thereof |
| 05/16/2013 | WO2013009057A9 Xenograft-derived bone grafting substitute and method for manufacturing same |